Journey Medical (DERM) Retained Earnings (2020 - 2026)
Journey Medical's (DERM) quarterly Retained Earnings came in at $131.5 million in Q1 2026, up 244.36% YoY from $38.2 million in Q1 2025, and up 233.58% on a QoQ basis from -$98.5 million in Q4 2025.
Journey Medical (DERM) Retained Earnings (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Retained Earnings data on file, last reported at $131.5 million in Q1 2026.
- Quarterly Retained Earnings rose 244.36% year-over-year to $131.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $131.5 million (up 244.36% YoY) and the FY2025 annual result came in at -$98.5 million, down 191.94% from the prior year.
- Retained Earnings advanced to $131.5 million in Q1 2026, from -$98.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $131.5 million in Q1 2026 to a low of -$98.5 million in Q4 2025.
- A 5-year average of $10.2 million and a median of -$40.3 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings plunged 1168.91% — and 2023, when it surged 313.97%.
- Tracing DERM's Retained Earnings over 5 years: stood at -$68.5 million in 2022, then soared by 235.33% to $92.7 million in 2023, then grew by 15.52% to $107.1 million in 2024, then plunged by 191.94% to -$98.5 million in 2025, then surged by 233.58% to $131.5 million in 2026.
- The last three Retained Earnings figures came in at $131.5 million (Q1 2026), -$98.5 million (Q4 2025), and $123.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Journey Medical | 212.53 Mn | 186.88 Mn | 12.37 Mn | 133.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 133.11 Mn |
| Mar 31, 2026 | 131.52 Mn |
| Dec 31, 2025 | -98.46 Mn |
| Sep 30, 2025 | 123.11 Mn |
| Jun 30, 2025 | -94.90 Mn |
| Mar 31, 2025 | -91.10 Mn |
| Dec 31, 2024 | 107.09 Mn |
| Sep 30, 2024 | 99.47 Mn |
| Jun 30, 2024 | 97.45 Mn |
| Mar 31, 2024 | -82.80 Mn |
| Dec 31, 2023 | 92.70 Mn |
| Sep 30, 2023 | -70.21 Mn |
| Jun 30, 2023 | 87.00 Mn |
| Mar 31, 2023 | 86.13 Mn |
| Dec 31, 2022 | -68.50 Mn |
| Sep 30, 2022 | -57.86 Mn |
| Jun 30, 2022 | -47.78 Mn |
| Mar 31, 2022 | -40.25 Mn |
| Dec 31, 2021 | 80.92 Mn |
| Sep 30, 2021 | 5.41 Mn |